The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

This publication has 20 references indexed in Scilit:

• The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• HMG CoA reductase inhibitors
  Current Opinion in Lipidology, 1992
• Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects A double blind test
  Atherosclerosis, 1988
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Lipid-Lowering Drugs
  Drugs, 1987
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1983
• Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase
  European Journal of Biochemistry, 1977
• Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
  FEBS Letters, 1976